<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:video="http://www.google.com/schemas/sitemap-video/1.1">
<url>
<loc>https://zyratrack.com/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>1</priority>
</url>
<url>
<loc>https://zyratrack.com/calculator/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.9</priority>
</url>
<url>
<loc>https://zyratrack.com/half-life/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.9</priority>
</url>
<url>
<loc>https://zyratrack.com/compounds/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.9</priority>
</url>
<url>
<loc>https://zyratrack.com/methodology/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.9</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.9</priority>
</url>
<url>
<loc>https://zyratrack.com/glossary/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.9</priority>
</url>
<url>
<loc>https://zyratrack.com/forum</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.9</priority>
</url>
<url>
<loc>https://zyratrack.com/privacy/</loc>
<lastmod>2026-08-22</lastmod>
<changefreq>monthly</changefreq>
<priority>0.3</priority>
</url>
<url>
<loc>https://zyratrack.com/terms/</loc>
<lastmod>2026-08-22</lastmod>
<changefreq>monthly</changefreq>
<priority>0.3</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/page/2/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/page/3/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/page/4/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/page/5/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/page/6/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/page/7/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/page/8/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/page/9/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/page/10/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/page/11/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/category/comparisons/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/category/how-to/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/category/pharmacology/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/category/compounds/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/category/tracking/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/category/app-guides/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://zyratrack.com/calculator/semaglutide/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/half-life/semaglutide/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/dose-charts/semaglutide/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/calculator/tirzepatide/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/half-life/tirzepatide/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/dose-charts/tirzepatide/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/calculator/bpc-157/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/half-life/bpc-157/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/dose-charts/bpc-157/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/calculator/tb-500/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/half-life/tb-500/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/dose-charts/tb-500/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/calculator/ipamorelin/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/half-life/ipamorelin/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/dose-charts/ipamorelin/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/calculator/cjc-1295/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/half-life/cjc-1295/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/dose-charts/cjc-1295/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/calculator/testosterone-cypionate/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/half-life/testosterone-cypionate/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/dose-charts/testosterone-cypionate/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/calculator/anastrozole/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/half-life/anastrozole/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/dose-charts/anastrozole/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/calculator/hcg/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/half-life/hcg/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/dose-charts/hcg/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/calculator/retatrutide/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/half-life/retatrutide/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/dose-charts/retatrutide/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/calculator/ghk-cu/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/half-life/ghk-cu/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/dose-charts/ghk-cu/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/calculator/pt-141/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/half-life/pt-141/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/dose-charts/pt-141/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/calculator/cagrilintide/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/half-life/cagrilintide/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/dose-charts/cagrilintide/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/calculator/ghrp-6/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/half-life/ghrp-6/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/dose-charts/ghrp-6/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/calculator/ghrp-2/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/half-life/ghrp-2/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/dose-charts/ghrp-2/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/calculator/thymosin-alpha-1/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/half-life/thymosin-alpha-1/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/dose-charts/thymosin-alpha-1/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/calculator/liraglutide/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/half-life/liraglutide/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/dose-charts/liraglutide/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/calculator/survodutide/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/half-life/survodutide/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/dose-charts/survodutide/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/calculator/mazdutide/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/half-life/mazdutide/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/dose-charts/mazdutide/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/calculator/gonadorelin/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/half-life/gonadorelin/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/dose-charts/gonadorelin/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/calculator/ss-31/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/half-life/ss-31/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/dose-charts/ss-31/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/calculator/igf-1-lr3/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/half-life/igf-1-lr3/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/dose-charts/igf-1-lr3/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/calculator/tesamorelin/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/half-life/tesamorelin/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/dose-charts/tesamorelin/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/calculator/mk-677/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/half-life/mk-677/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/dose-charts/mk-677/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/calculator/dihexa/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/half-life/dihexa/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/dose-charts/dihexa/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/calculator/aod-9604/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/half-life/aod-9604/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/dose-charts/aod-9604/</loc>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/bpc-157-vs-tb-500/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/cjc-1295-vs-ipamorelin/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/sermorelin-vs-cjc-1295-vs-ipamorelin/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/semaglutide-vs-tirzepatide/</loc>
<video:video>
<video:title>Semaglutide vs tirzepatide vs retatrutide: which stays in your system longest?</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/half-life-race-poster.jpg</video:thumbnail_loc>
<video:description>Three weekly injections, three clocks: tirzepatide&apos;s half-life is ~5 days (effectively cleared around day 25 after the last dose), retatrutide ~6 days (~day 30), semaglutide ~7 days (~day 35) — using pharmacology&apos;s five-half-lives rule. The same clock also means longer half-life = steadier levels be</video:description>
<video:content_loc>https://zyratrack.com/media/half-life-race-5db790e0.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>You can&apos;t rank these three: what the obesity trials actually found</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/trials-rank-poster.jpg</video:thumbnail_loc>
<video:description>Retatrutide 24%, tirzepatide 21%, semaglutide 15% — you have seen that ranking, and it is three separate trials stacked as if they were one. Here is where each figure comes from. Semaglutide&apos;s is STEP 1 (NEJM 2021, PMID 33567185): 68 weeks, 1,961 adults, a mean 14.9% of body weight versus 2.4% on pl</video:description>
<video:content_loc>https://zyratrack.com/media/trials-rank-97d93218.mp4</video:content_loc>
</video:video>
<lastmod>2026-08-21T12:32:42Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/testosterone-cypionate-vs-enanthate/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/cjc-1295-dac-vs-no-dac/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/ozempic-wegovy-mounjaro-zepbound-difference/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/retatrutide-vs-tirzepatide/</loc>
<video:video>
<video:title>You can&apos;t rank these three: what the obesity trials actually found</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/trials-rank-poster.jpg</video:thumbnail_loc>
<video:description>Retatrutide 24%, tirzepatide 21%, semaglutide 15% — you have seen that ranking, and it is three separate trials stacked as if they were one. Here is where each figure comes from. Semaglutide&apos;s is STEP 1 (NEJM 2021, PMID 33567185): 68 weeks, 1,961 adults, a mean 14.9% of body weight versus 2.4% on pl</video:description>
<video:content_loc>https://zyratrack.com/media/trials-rank-97d93218.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>Semaglutide vs tirzepatide vs retatrutide: which stays in your system longest?</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/half-life-race-poster.jpg</video:thumbnail_loc>
<video:description>Three weekly injections, three clocks: tirzepatide&apos;s half-life is ~5 days (effectively cleared around day 25 after the last dose), retatrutide ~6 days (~day 30), semaglutide ~7 days (~day 35) — using pharmacology&apos;s five-half-lives rule. The same clock also means longer half-life = steadier levels be</video:description>
<video:content_loc>https://zyratrack.com/media/half-life-race-5db790e0.mp4</video:content_loc>
</video:video>
<lastmod>2026-08-21T12:32:42Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/ipamorelin-vs-ghrp-6-vs-ghrp-2/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/tesamorelin-vs-cjc-1295/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/how-to-reconstitute-peptides/</loc>
<video:video>
<video:title>Peptide reconstitution: the 4-step how-to (don&apos;t shake!)</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/reconstitution-poster.jpg</video:thumbnail_loc>
<video:description>How to reconstitute peptides in 4 steps: wipe both stoppers, draw bacteriostatic water, inject it slowly down the inside wall of the vial, then swirl gently — never shake — until completely clear. Then the math: (your dose ÷ vial mg) × water in ml × 100 = units on an insulin syringe. Free peptide re</video:description>
<video:content_loc>https://zyratrack.com/media/reconstitution-20a5461e.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>How much bac water do I add? (it never changes your dose)</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/pm-water-poster.jpg</video:thumbnail_loc>
<video:description>How much bacteriostatic water do I add? Trick question: the water does not change your dose, it changes how big the draw is. Less water, stronger mix, smaller draw; more water, weaker mix, bigger draw — the peptide in the syringe is identical either way. Too little water and the dose is only a few u</video:description>
<video:content_loc>https://zyratrack.com/media/pm-water-ad868e8a.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>5 mg vial is how many doses? (the water isn&apos;t in the sum)</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/pm-doses-poster.jpg</video:thumbnail_loc>
<video:description>How many doses are in a 5 mg vial? One division: the vial divided by the dose. 5 mg at 250 mcg is 20 doses — and the bacteriostatic water you add is not in that sum. Add 1 mL or 3 mL and it is still 20: the water only sets how big each draw is, never how many draws there are. Two things people get w</video:description>
<video:content_loc>https://zyratrack.com/media/pm-doses-5a82bf5d.mp4</video:content_loc>
</video:video>
<lastmod>2026-08-21T12:32:42Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/how-to-reconstitute-semaglutide/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/how-to-reconstitute-tirzepatide/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/how-to-reconstitute-retatrutide/</loc>
<video:video>
<video:title>Retatrutide reconstitution: the complete guide (BAC water, mixing, mg to units)</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/retatrutide-guide-poster.jpg</video:thumbnail_loc>
<video:description>The complete retatrutide reconstitution guide: what you need (vial sizes, bacteriostatic water, U-100 insulin syringes), why the amount of BAC water never changes your dose — it only sets the concentration, the four mixing steps (wipe both stoppers, water down the glass wall, swirl — never shake — u</video:description>
<video:content_loc>https://zyratrack.com/media/retatrutide-guide-251389c0.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>Retatrutide reconstitution calculator: mg to units in 20 seconds</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/calc-demo-poster.jpg</video:thumbnail_loc>
<video:description>The free retatrutide reconstitution calculator at ZyraTrack: enter vial mg, BAC water ml, and your dose in mcg — it instantly gives the concentration, your exact U-100 syringe draw in units, and doses per vial, using the documented formula (units = dose ÷ (vial mg ÷ water ml) × 100). Presets for tir</video:description>
<video:content_loc>https://zyratrack.com/media/calc-demo-7683838f.mp4</video:content_loc>
</video:video>
<lastmod>2026-08-21T12:32:42Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/reconstitution-solution-vs-bacteriostatic-water/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-bacteriostatic-water/</loc>
<video:video>
<video:title>What is BAC water? The 0.9% that makes peptide vials multi-dose</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/bac-water-poster.jpg</video:thumbnail_loc>
<video:description>Bacteriostatic water (BAC water) explained: sterile water with 0.9% benzyl alcohol, which stops bacteria growing in the vial — that&apos;s the only difference from single-use sterile water, and it&apos;s why reconstituted peptide vials can be drawn from for weeks. How much BAC water for your vial? Free peptid</video:description>
<video:content_loc>https://zyratrack.com/media/bac-water-24b7e31d.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>How much bac water do I add? (it never changes your dose)</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/pm-water-poster.jpg</video:thumbnail_loc>
<video:description>How much bacteriostatic water do I add? Trick question: the water does not change your dose, it changes how big the draw is. Less water, stronger mix, smaller draw; more water, weaker mix, bigger draw — the peptide in the syringe is identical either way. Too little water and the dose is only a few u</video:description>
<video:content_loc>https://zyratrack.com/media/pm-water-ad868e8a.mp4</video:content_loc>
</video:video>
<lastmod>2026-08-21T12:32:42Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/bac-water-for-peptides/</loc>
<video:video>
<video:title>What is BAC water? The 0.9% that makes peptide vials multi-dose</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/bac-water-poster.jpg</video:thumbnail_loc>
<video:description>Bacteriostatic water (BAC water) explained: sterile water with 0.9% benzyl alcohol, which stops bacteria growing in the vial — that&apos;s the only difference from single-use sterile water, and it&apos;s why reconstituted peptide vials can be drawn from for weeks. How much BAC water for your vial? Free peptid</video:description>
<video:content_loc>https://zyratrack.com/media/bac-water-24b7e31d.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>How much bac water do I add? (it never changes your dose)</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/pm-water-poster.jpg</video:thumbnail_loc>
<video:description>How much bacteriostatic water do I add? Trick question: the water does not change your dose, it changes how big the draw is. Less water, stronger mix, smaller draw; more water, weaker mix, bigger draw — the peptide in the syringe is identical either way. Too little water and the dose is only a few u</video:description>
<video:content_loc>https://zyratrack.com/media/pm-water-ad868e8a.mp4</video:content_loc>
</video:video>
<lastmod>2026-08-21T12:32:42Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/best-peptide-reconstitution-calculator/</loc>
<video:video>
<video:title>Retatrutide reconstitution calculator: mg to units in 20 seconds</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/calc-demo-poster.jpg</video:thumbnail_loc>
<video:description>The free retatrutide reconstitution calculator at ZyraTrack: enter vial mg, BAC water ml, and your dose in mcg — it instantly gives the concentration, your exact U-100 syringe draw in units, and doses per vial, using the documented formula (units = dose ÷ (vial mg ÷ water ml) × 100). Presets for tir</video:description>
<video:content_loc>https://zyratrack.com/media/calc-demo-7683838f.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>Peptide math: 2mg is how many units? The 30-second syringe answer</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/mg-to-units-poster.jpg</video:thumbnail_loc>
<video:description>The peptide mg → units formula for any insulin syringe: (your dose ÷ vial mg) × water in ml × 100 = units. Works for any peptide reconstitution. Free peptide calculator: — this is the official ZyraTrack channel; the</video:description>
<video:content_loc>https://zyratrack.com/media/mg-to-units-42250778.mp4</video:content_loc>
</video:video>
<lastmod>2026-08-21T12:32:42Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/how-to-read-an-insulin-syringe/</loc>
<video:video>
<video:title>Is my syringe U-100 or U-40? (same 20 units, 2.5× the peptide)</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/pm-u40-poster.jpg</video:thumbnail_loc>
<video:description>Is my syringe U-100 or U-40? Two syringes, the same 20-unit mark, and one holds two and a half times more. Insulin syringes are not one thing: U-100 means 100 units per millilitre, U-40 means 40. So a unit is not a fixed amount of liquid — on a U-100 it is a hundredth of a millilitre, on a U-40 a fo</video:description>
<video:content_loc>https://zyratrack.com/media/pm-u40-02886b0b.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>Peptide math: 2mg is how many units? The 30-second syringe answer</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/mg-to-units-poster.jpg</video:thumbnail_loc>
<video:description>The peptide mg → units formula for any insulin syringe: (your dose ÷ vial mg) × water in ml × 100 = units. Works for any peptide reconstitution. Free peptide calculator: — this is the official ZyraTrack channel; the</video:description>
<video:content_loc>https://zyratrack.com/media/mg-to-units-42250778.mp4</video:content_loc>
</video:video>
<lastmod>2026-08-21T12:32:42Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/mcg-mg-iu-units-conversion/</loc>
<video:video>
<video:title>20 units is how many mg? Units measure liquid, not peptide</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/units-to-mg-poster.jpg</video:thumbnail_loc>
<video:description>A syringe reading is a volume, not a dose — so the same 20 units can be two completely different amounts of peptide. Take a 10 mg vial. Reconstitute it with 1 mL of bacteriostatic water and you have 10 mg/mL; 20 units on a U-100 syringe is 0.2 mL, so that draw is 2 mg. Reconstitute the same vial wit</video:description>
<video:content_loc>https://zyratrack.com/media/units-to-mg-8fe9fcfd.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>Peptide math: 2mg is how many units? The 30-second syringe answer</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/mg-to-units-poster.jpg</video:thumbnail_loc>
<video:description>The peptide mg → units formula for any insulin syringe: (your dose ÷ vial mg) × water in ml × 100 = units. Works for any peptide reconstitution. Free peptide calculator: — this is the official ZyraTrack channel; the</video:description>
<video:content_loc>https://zyratrack.com/media/mg-to-units-42250778.mp4</video:content_loc>
</video:video>
<lastmod>2026-08-21T12:32:42Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/how-to-store-reconstituted-peptides/</loc>
<video:video>
<video:title>How long does a reconstituted peptide last? Two clocks, not one</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/shelf-life-poster.jpg</video:thumbnail_loc>
<video:description>Everyone quotes 28 days. That number isn&apos;t on the bacteriostatic water label at all — it comes from USP &lt;797&gt;, the pharmacy standard for a punctured multi-dose vial, and it&apos;s about contamination. Whether the peptide itself is still intact is a second clock, and for compounded peptides nobody has pub</video:description>
<video:content_loc>https://zyratrack.com/media/shelf-life-a9443d77.mp4</video:content_loc>
</video:video>
<lastmod>2026-08-21T12:32:42Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/how-long-do-reconstituted-peptides-last/</loc>
<video:video>
<video:title>How long does a reconstituted peptide last? Two clocks, not one</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/shelf-life-poster.jpg</video:thumbnail_loc>
<video:description>Everyone quotes 28 days. That number isn&apos;t on the bacteriostatic water label at all — it comes from USP &lt;797&gt;, the pharmacy standard for a punctured multi-dose vial, and it&apos;s about contamination. Whether the peptide itself is still intact is a second clock, and for compounded peptides nobody has pub</video:description>
<video:content_loc>https://zyratrack.com/media/shelf-life-a9443d77.mp4</video:content_loc>
</video:video>
<lastmod>2026-08-21T12:32:42Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/can-you-freeze-reconstituted-peptides/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/why-is-my-peptide-cloudy/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-color-should-tirzepatide-be/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/how-to-draw-a-subcutaneous-injection/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/how-to-store-peptides/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-a-half-life/</loc>
<video:video>
<video:title>Semaglutide vs tirzepatide vs retatrutide: which stays in your system longest?</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/half-life-race-poster.jpg</video:thumbnail_loc>
<video:description>Three weekly injections, three clocks: tirzepatide&apos;s half-life is ~5 days (effectively cleared around day 25 after the last dose), retatrutide ~6 days (~day 30), semaglutide ~7 days (~day 35) — using pharmacology&apos;s five-half-lives rule. The same clock also means longer half-life = steadier levels be</video:description>
<video:content_loc>https://zyratrack.com/media/half-life-race-5db790e0.mp4</video:content_loc>
</video:video>
<lastmod>2026-08-21T12:32:42Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/understanding-steady-state/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/how-long-does-semaglutide-stay-in-your-system/</loc>
<video:video>
<video:title>How long does semaglutide stay in your system? The half-life math</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/sema-half-life-poster.jpg</video:thumbnail_loc>
<video:description>Semaglutide&apos;s half-life is about 7 days — one week after a dose, half is still in your system. The pharmacology rule of thumb: about 5 half-lives (~5 weeks) to effectively clear, and the same ~5 half-lives for levels to plateau while dosing weekly. See your own peptide half-life curve — rising, plat</video:description>
<video:content_loc>https://zyratrack.com/media/sema-half-life-6f384030.mp4</video:content_loc>
</video:video>
<lastmod>2026-08-21T12:32:42Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/how-long-does-tirzepatide-stay-in-your-system/</loc>
<video:video>
<video:title>How long does tirzepatide (Mounjaro) stay in your system? Half-life math</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/tirz-half-life-poster.jpg</video:thumbnail_loc>
<video:description>Tirzepatide — the active ingredient in Mounjaro and Zepbound — has a half-life of about 5 days: five days after a dose, half is still in your system. The pharmacology rule of thumb: about 5 half-lives (~25 days) to effectively clear, and levels plateau after about 4 weeks of weekly dosing. See your</video:description>
<video:content_loc>https://zyratrack.com/media/tirz-half-life-5d0150fd.mp4</video:content_loc>
</video:video>
<lastmod>2026-08-21T12:32:42Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-happens-if-you-miss-a-semaglutide-dose/</loc>
<video:video>
<video:title>What happens if you miss a dose? (one number decides)</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/pm-missed-poster.jpg</video:thumbnail_loc>
<video:description>What happens if you miss a dose? Semaglutide and ipamorelin give two completely different answers, and one number decides: the half life. Semaglutide&apos;s half life is about 7 days — two days late, your level sits about 18% below its usual low; a whole week late, exactly half. Not zero: zero takes abou</video:description>
<video:content_loc>https://zyratrack.com/media/pm-missed-61138b86.mp4</video:content_loc>
</video:video>
<lastmod>2026-08-21T12:32:42Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-happens-if-you-miss-a-tirzepatide-dose/</loc>
<video:video>
<video:title>What happens if you miss a dose? (one number decides)</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/pm-missed-poster.jpg</video:thumbnail_loc>
<video:description>What happens if you miss a dose? Semaglutide and ipamorelin give two completely different answers, and one number decides: the half life. Semaglutide&apos;s half life is about 7 days — two days late, your level sits about 18% below its usual low; a whole week late, exactly half. Not zero: zero takes abou</video:description>
<video:content_loc>https://zyratrack.com/media/pm-missed-61138b86.mp4</video:content_loc>
</video:video>
<lastmod>2026-08-21T12:32:42Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/why-glp-1-medications-are-weekly/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/bpc-157-half-life-explained/</loc>
<video:video>
<video:title>How BPC-157 is supposed to work (2/9)</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/bpc-how-poster.jpg</video:thumbnail_loc>
<video:description>The mechanism people claim, and where it comes from. In cell work, BPC-157 made tendon cells migrate and adhere via the FAK-paxillin pathway (Chang 2011, J Appl Physiol, PMID 21030672), and a separate study reported upregulation of the growth-hormone receptor in tendon fibroblasts (Chang 2014, Molec</video:description>
<video:content_loc>https://zyratrack.com/media/bpc-how-dc83b526.mp4</video:content_loc>
</video:video>
<lastmod>2026-08-21T12:32:42Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/understanding-peptide-concentration/</loc>
<video:video>
<video:title>5 mg vial is how many doses? (the water isn&apos;t in the sum)</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/pm-doses-poster.jpg</video:thumbnail_loc>
<video:description>How many doses are in a 5 mg vial? One division: the vial divided by the dose. 5 mg at 250 mcg is 20 doses — and the bacteriostatic water you add is not in that sum. Add 1 mL or 3 mL and it is still 20: the water only sets how big each draw is, never how many draws there are. Two things people get w</video:description>
<video:content_loc>https://zyratrack.com/media/pm-doses-5a82bf5d.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>20 units is how many mg? Units measure liquid, not peptide</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/units-to-mg-poster.jpg</video:thumbnail_loc>
<video:description>A syringe reading is a volume, not a dose — so the same 20 units can be two completely different amounts of peptide. Take a 10 mg vial. Reconstitute it with 1 mL of bacteriostatic water and you have 10 mg/mL; 20 units on a U-100 syringe is 0.2 mL, so that draw is 2 mg. Reconstitute the same vial wit</video:description>
<video:content_loc>https://zyratrack.com/media/units-to-mg-8fe9fcfd.mp4</video:content_loc>
</video:video>
<lastmod>2026-08-21T12:32:42Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/subq-vs-im-injections/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/glp-1-receptor-agonists-explained/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/growth-hormone-secretagogues-explained/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-bpc-157/</loc>
<video:video>
<video:title>BPC-157: the peptide with no human trial (1/9)</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/bpc-what-poster.jpg</video:thumbnail_loc>
<video:description>Everyone argues about BPC-157; almost nobody publishes data on it. It is a 15-amino-acid fragment of a protein found in human gastric juice — the fragment itself is made in a lab, not by your body. The rodent literature is large and the human literature is nearly empty: roughly three small pilots an</video:description>
<video:content_loc>https://zyratrack.com/media/bpc-what-fcc4bb7d.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>How BPC-157 is supposed to work (2/9)</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/bpc-how-poster.jpg</video:thumbnail_loc>
<video:description>The mechanism people claim, and where it comes from. In cell work, BPC-157 made tendon cells migrate and adhere via the FAK-paxillin pathway (Chang 2011, J Appl Physiol, PMID 21030672), and a separate study reported upregulation of the growth-hormone receptor in tendon fibroblasts (Chang 2014, Molec</video:description>
<video:content_loc>https://zyratrack.com/media/bpc-how-dc83b526.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>Rats healed. Humans were never tested. (3/9)</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/bpc-studies-poster.jpg</video:thumbnail_loc>
<video:description>What the BPC-157 literature actually contains. Rats had their Achilles tendons transected — cut clean through — and the treated animals healed better (Staresinic 2003, J Orthop Res). That result is real, and it is in rats. On the human side there are roughly three small pilots and no randomized cont</video:description>
<video:content_loc>https://zyratrack.com/media/bpc-studies-252aa657.mp4</video:content_loc>
</video:video>
<lastmod>2026-08-21T12:32:42Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-tb-500/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-ipamorelin/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-cjc-1295/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-semaglutide/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-tirzepatide/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-tesamorelin/</loc>
<video:video>
<video:title>Tesamorelin&apos;s own label says it&apos;s not for weight loss</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/tesa-label-poster.jpg</video:thumbnail_loc>
<video:description>The most-searched thing about tesamorelin is whether it causes weight loss. Its FDA label answers that directly: EGRIFTA WR is &quot;not indicated for weight loss management as it has a weight neutral effect.&quot; Here is what it actually is and what the trials actually found. Tesamorelin is a growth-hormone</video:description>
<video:content_loc>https://zyratrack.com/media/tesa-label-75b40ed7.mp4</video:content_loc>
</video:video>
<lastmod>2026-08-21T12:32:42Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-sermorelin/</loc>
<lastmod>2026-07-14T15:53:55Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-hcg/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-anastrozole/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-testosterone-cypionate/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-are-research-peptides/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-retatrutide/</loc>
<video:video>
<video:title>Retatrutide 1/6 — Three hormones, one molecule</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/reta-mechanism-poster.jpg</video:thumbnail_loc>
<video:description>One of retatrutide&apos;s three hormones raises blood sugar — on purpose. Retatrutide is a triple agonist: GLP-1, GIP, and glucagon receptors in one molecule. GLP-1 and GIP work the intake side — appetite down, slower gastric emptying, glucose-dependent insulin release. Glucagon is the odd one out: it dr</video:description>
<video:content_loc>https://zyratrack.com/media/reta-mechanism-13daca9d.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>Retatrutide 2/6 — 28.3… or 30.3?</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/reta-numbers-poster.jpg</video:thumbnail_loc>
<video:description>Lilly published two different weight-loss numbers for the same trial — and both are true. TRIUMPH-1 reported 28.3% under the treatment-regimen estimand (everyone who started, dropouts included) and 30.3% under the efficacy estimand (participants who stayed on treatment). Same trial, same data, two c</video:description>
<video:content_loc>https://zyratrack.com/media/reta-numbers-903a6a93.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>Retatrutide 3/6 — The table that comes with the number</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/reta-table-poster.jpg</video:thumbnail_loc>
<video:description>The biggest weight-loss number in obesity medicine comes with a table — TRIUMPH-1&apos;s own adverse-event data, with placebo beside every number. Top dose (12 mg): nausea 42.4% vs 14.8% placebo, diarrhea 32.0% vs 13.5%, constipation 26.1% vs 10.9%, vomiting 25.3% vs 4.8% — generally mild to moderate per</video:description>
<video:content_loc>https://zyratrack.com/media/reta-table-6a4545bd.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>Retatrutide 4/6 — Six days</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/reta-sixdays-poster.jpg</video:thumbnail_loc>
<video:description>Retatrutide&apos;s half-life is approximately six days — measured in the phase 1b multiple-ascending-dose trial (Urva et al., The Lancet 2022, PMID 36354040), with dose-proportional pharmacokinetics and once-weekly dosing. Everything else follows from arithmetic: every six days whatever remains drops by</video:description>
<video:content_loc>https://zyratrack.com/media/reta-sixdays-f23cb288.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>Retatrutide 5/6 — The trials nobody quotes</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/reta-quiet-poster.jpg</video:thumbnail_loc>
<video:description>Everyone quotes retatrutide&apos;s 28.3% — the broadest trial. The quiet trials took the harder cases. TRIUMPH-2 and TRIUMPH-3 enrolled severe obesity with established cardiovascular disease, some with type 2 diabetes, and those patients still lost up to 22.6% at 80 weeks, with A1C falling too (Lilly, 20</video:description>
<video:content_loc>https://zyratrack.com/media/reta-quiet-a727a678.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>Retatrutide 6/6 — Why you can&apos;t get it</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/reta-locked-poster.jpg</video:thumbnail_loc>
<video:description>Retatrutide beat every number on the board — and it is not for sale. It is not FDA approved, in the United States or anywhere else. The application is not even filed: Lilly plans to submit the BLA in Q1 2027, and FDA review after filing runs about ten months standard or six months priority. So the e</video:description>
<video:content_loc>https://zyratrack.com/media/reta-locked-88952a0e.mp4</video:content_loc>
</video:video>
<lastmod>2026-08-21T12:32:42Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-ghk-cu/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-ara-290/</loc>
<lastmod>2026-07-20T12:00:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-adipotide/</loc>
<lastmod>2026-07-20T12:00:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-ahk-cu/</loc>
<lastmod>2026-07-20T12:00:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-mgf/</loc>
<lastmod>2026-07-20T12:00:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-peg-mgf/</loc>
<lastmod>2026-07-20T12:00:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-are-khavinson-peptide-bioregulators/</loc>
<lastmod>2026-07-20T12:00:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-ace-031/</loc>
<lastmod>2026-07-20T12:00:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/how-to-track-a-peptide-protocol/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/why-log-injection-sites/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/injection-site-rotation-guide/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/building-a-protocol-schedule/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/reading-your-bloodwork-trends/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/compounded-vs-brand-glp1/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/is-compounded-semaglutide-legal/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/are-peptides-legal/</loc>
<lastmod>2026-07-16T17:25:54Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/is-bpc-157-legal/</loc>
<lastmod>2026-07-16T17:52:44Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/peptide-compounding-pharmacies-explained/</loc>
<lastmod>2026-07-16T17:53:51Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/fda-peptide-regulation-2026/</loc>
<lastmod>2026-07-16T17:56:44Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/bpc-157-what-people-actually-take/</loc>
<video:video>
<video:title>BPC-157: The File — everything we know, and what we don&apos;t</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/bpc-film-poster.jpg</video:thumbnail_loc>
<video:description>Nobody has run a proper trial on BPC-157. Millions of people did not wait. This is everything we could verify, and everything we could not — the complete series in one film, built on our own dataset of what people actually report. CHAPTERS
00:00 Cold open — the question an FDA reviewer asked out lo</video:description>
<video:content_loc>https://zyratrack.com/media/bpc-film-2d734a6d.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>BPC-157: the peptide with no human trial (1/9)</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/bpc-what-poster.jpg</video:thumbnail_loc>
<video:description>Everyone argues about BPC-157; almost nobody publishes data on it. It is a 15-amino-acid fragment of a protein found in human gastric juice — the fragment itself is made in a lab, not by your body. The rodent literature is large and the human literature is nearly empty: roughly three small pilots an</video:description>
<video:content_loc>https://zyratrack.com/media/bpc-what-fcc4bb7d.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>How BPC-157 is supposed to work (2/9)</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/bpc-how-poster.jpg</video:thumbnail_loc>
<video:description>The mechanism people claim, and where it comes from. In cell work, BPC-157 made tendon cells migrate and adhere via the FAK-paxillin pathway (Chang 2011, J Appl Physiol, PMID 21030672), and a separate study reported upregulation of the growth-hormone receptor in tendon fibroblasts (Chang 2014, Molec</video:description>
<video:content_loc>https://zyratrack.com/media/bpc-how-dc83b526.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>Rats healed. Humans were never tested. (3/9)</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/bpc-studies-poster.jpg</video:thumbnail_loc>
<video:description>What the BPC-157 literature actually contains. Rats had their Achilles tendons transected — cut clean through — and the treated animals healed better (Staresinic 2003, J Orthop Res). That result is real, and it is in rats. On the human side there are roughly three small pilots and no randomized cont</video:description>
<video:content_loc>https://zyratrack.com/media/bpc-studies-252aa657.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>We built the database BPC-157 never had (4/9)</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/bpc-data-poster.jpg</video:thumbnail_loc>
<video:description>Nobody has run a proper trial on BPC-157, so people ran their own, in public. Our research pipeline indexes public forums, comment threads and video transcripts. From 2,805 public mentions of BPC-157 we extracted 244 structured usage reports — concrete enough to state a dose, a route or a schedule —</video:description>
<video:content_loc>https://zyratrack.com/media/bpc-data-53c85350.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>65 said it worked. 5 said nothing. Both are true. (5/9)</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/bpc-happened-poster.jpg</video:thumbnail_loc>
<video:description>What 244 BPC-157 reports actually claim, and why the ratio lies. Sixty-five report a positive outcome, five report nothing happened, seven mention a side effect — persistent diarrhea, heart palpitations, and one case of headaches severe enough to end the protocol. The wins are recovery stories: tend</video:description>
<video:content_loc>https://zyratrack.com/media/bpc-happened-d4ead7ce.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>Everyone says 500. It means two different things. (6/9)</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/bpc-take-poster.jpg</video:thumbnail_loc>
<video:description>The dose census from 244 reports. One number dominates: 500 micrograms is both the median and the most common reported amount, and it is the same for injection and oral use — which is not what the folklore predicts. Quick translation: one milligram is one thousand micrograms, and the typical report</video:description>
<video:content_loc>https://zyratrack.com/media/bpc-take-86d5065e.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>The hangover study is real. It is not what you think. (7/9)</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/bpc-myths-poster.jpg</video:thumbnail_loc>
<video:description>Four things people believe about BPC-157, checked against primary sources. One: your body already makes it — half true. There is a protein in human gastric juice; BPC-157 is a 15-amino-acid fragment of it, built in a lab. Two: the claim that it cures hangovers — the studies are real and they are in</video:description>
<video:content_loc>https://zyratrack.com/media/bpc-myths-724fc0b3.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>The FDA panel said yes. Its own scientists said no. (8/9)</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/bpc-fda-poster.jpg</video:thumbnail_loc>
<video:description>Three things wrong with how July 2026 was reported. The Pharmacy Compounding Advisory Committee met on 23-24 July; seven peptides were considered and six were recommended, BPC-157 among them by 8-6. First: that was not a drug approval. It concerned the 503A bulk substances list — what compounding ph</video:description>
<video:content_loc>https://zyratrack.com/media/bpc-fda-90875a84.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>They sell it pre-mixed. Nobody tested the mix. (9/9)</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/bpc-stack-poster.jpg</video:thumbnail_loc>
<video:description>The finale. Of the 182 people in our dataset, 42 also report TB-500 — nearly one in four. That pairing has a nickname: the community calls it the wolverine stack, and our corpus mentions it 398 times. Add GHK-Cu and it becomes GLOW (348 mentions); add KPV on top and it becomes KLOW, four peptides (3</video:description>
<video:content_loc>https://zyratrack.com/media/bpc-stack-028dcd2b.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>What BPC-157 might turn out to do (bonus)</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/bpc-maybe-poster.jpg</video:thumbnail_loc>
<video:description>Nine videos on what we know; this one is what might turn out to be true and is not proven. Ground rule: everything here is an open question, in animals and cells, not a finding in people. Tendons — transected rat Achilles tendons healed better, and cell work shows tendon cells migrating and adhering</video:description>
<video:content_loc>https://zyratrack.com/media/bpc-maybe-25ea97b6.mp4</video:content_loc>
</video:video>
<lastmod>2026-08-21T12:32:42Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/ss-31-what-people-actually-take/</loc>
<video:video>
<video:title>SS-31: The Trial That Finished — what a completed human trial found, and what 117 people did anyway</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/ss-film-poster.jpg</video:thumbnail_loc>
<video:description>The complete SS-31 (elamipretide) investigation in one film. There is an approved medicine in this story and there is an internet protocol — same molecule, different dose, different disease, different evidence. Ten chapters: the phase 3 that finished and missed (−3.2 metres, p 0.69); the post-hoc su</video:description>
<video:content_loc>https://zyratrack.com/media/ss-film-accd2d06.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>SS-31 finished a real phase 3 trial. It came back negative. (1/10)</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/ss-1-metres-poster.jpg</video:thumbnail_loc>
<video:description>Most research peptides never get a human trial. SS-31 (elamipretide) did: MMPOWER-3, 218 adults with primary mitochondrial myopathy, 24 weeks at 40 mg a day, against placebo. On the six-minute walk test the drug group finished 3.2 metres short of placebo (95% CI −18.7 to 12.3, p = 0.69). The fatigue</video:description>
<video:content_loc>https://zyratrack.com/media/ss-1-metres-2b2ddfb3.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>Inside the failed SS-31 trial, one group walked 25 m further. Why that is not the headline. (2/10)</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/ss-2-signal-poster.jpg</video:thumbnail_loc>
<video:description>The phase 3 missed every primary and secondary endpoint. Then the authors split patients by genetics: those with nuclear-DNA mutations (27% of the trial) walked 25.2 metres further on the drug than on placebo (p = 0.03, 29 vs 29 people); those with mitochondrial-DNA mutations walked 11 metres less.</video:description>
<video:content_loc>https://zyratrack.com/media/ss-2-signal-18429dcb.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>SS-31 is an approved medicine — for a disease almost nobody watching has (3/10)</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/ss-3-approval-poster.jpg</video:thumbnail_loc>
<video:description>Elamipretide, brand name Forzinity, is approved for Barth syndrome: a genetic mitochondrial disorder affecting about one child in every 300,000 to 400,000 born, almost always boys. Barth patients kept on the drug for years held their walking distance and heart measures through a 168-week extension,</video:description>
<video:content_loc>https://zyratrack.com/media/ss-3-approval-8f68991c.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>Why 117 people take a peptide that failed its trial: the mitochondria brochure (4/10)</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/ss-4-hope-poster.jpg</video:thumbnail_loc>
<video:description>Our pipeline reads public discussion — for SS-31 that is the transcripts of 90 videos and the comments under 172, about 1,500 passages. The story in them is mitochondria: 352 passages say the word, and 789 also name MOTS-c, because it is pitched as a stack. The belief has real roots — the peptide do</video:description>
<video:content_loc>https://zyratrack.com/media/ss-4-hope-3a8b0340.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>19 people said 40 mg. One was actually taking it. (5/10)</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/ss-5-quoted-poster.jpg</video:thumbnail_loc>
<video:description>Nineteen records in our SS-31 log mention 40 milligrams — the trial dose — and we nearly reported that as bold dosing. Then we read them. They are people quoting the trial (“the dose that was used that gave these results was 40mg”) and reading the label out loud. A speed sign says the limit; everyon</video:description>
<video:content_loc>https://zyratrack.com/media/ss-5-quoted-154c2861.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>The trial tested SS-31 with a bucket. People use a shot glass. (6/10)</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/ss-6-twentieth-poster.jpg</video:thumbnail_loc>
<video:description>How our log is built: about 1,500 public passages mention SS-31; our pipeline extracted 290 usage records from them; keep only people describing their own use and that is 197 reports from 117 people. Their typical dose is 2 mg a day. The trial’s was 40. Same molecule, one twentieth of the amount — a</video:description>
<video:content_loc>https://zyratrack.com/media/ss-6-twentieth-f9ff4b44.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>One word wears three hats in the SS-31 story: fatigue (7/10)</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/ss-7-fatigue-poster.jpg</video:thumbnail_loc>
<video:description>The trial measured fatigue as a primary endpoint and found nothing (−0.07, p = 0.37). In our log, when people describe something going wrong, half the time the word is exhaustion or fatigue — 10 of 20 adverse reports. And two people describe starting SS-31 because of chronic fatigue (“I have severe</video:description>
<video:content_loc>https://zyratrack.com/media/ss-7-fatigue-54cb53a0.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>Did SS-31 work? 38 said yes, 14 said no, 143 never answered. (8/10)</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/ss-8-silences-poster.jpg</video:thumbnail_loc>
<video:description>Picture a classroom of everyone in our log. The teacher asks: did it work? Thirty-eight hands say yes, fourteen say no, and 143 people never answer at all. The silence is the biggest thing in the room. Here is the catch: the people who felt nothing do not raise a hand, and they do not write a post e</video:description>
<video:content_loc>https://zyratrack.com/media/ss-8-silences-ea384e34.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>The SS-31 trial ran 24 weeks. Nobody in our log got past 12. (9/10)</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/ss-9-duration-poster.jpg</video:thumbnail_loc>
<video:description>Think of the trial as a marathon: 24 weeks of daily injections. Of the 52 reports that say how long they ran it, 45 stopped inside six weeks; the typical run is about a month; the longest anyone describes is 12 weeks — half the distance of the trial that missed. The run that earned the approval, in</video:description>
<video:content_loc>https://zyratrack.com/media/ss-9-duration-938a7927.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>What 197 SS-31 reports cannot tell you (10/10)</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/ss-10-ledger-poster.jpg</video:thumbnail_loc>
<video:description>Our log as a receipt: 197 lines, with whole columns torn off. Nobody’s purchase is verified, no vial was tested, nothing was weighed, and one in five of these people name another compound in the same breath — so even a clear win could not be pinned on this one. What the receipt does hold: 117 people</video:description>
<video:content_loc>https://zyratrack.com/media/ss-10-ledger-c7757518.mp4</video:content_loc>
</video:video>
<lastmod>2026-08-21T19:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/slu-pp-332-what-people-actually-take/</loc>
<video:video>
<video:title>SLU-PP-332: The File — the exercise pill that isn&apos;t</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/slu-film-poster.jpg</video:thumbnail_loc>
<video:description>The complete SLU-PP-332 investigation in one film. Its inventors wrote that it &quot;lacks oral bioavailability&quot;; in our log, of the 216 reports we hold, 101 name a route and 78 of those describe swallowing it. Nine chapters: what the compound is, the oral contradiction, a community split 100-to-112 on w</video:description>
<video:content_loc>https://zyratrack.com/media/slu-film-5b8ca11a.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>SLU-PP-332: the exercise pill that only worked in mice (1/9)</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/slu-1-pill-poster.jpg</video:thumbnail_loc>
<video:description>SLU-PP-332 is sold as “exercise in a pill”. It is a synthetic pan-agonist of the ERR nuclear receptors — the switches muscle uses to build mitochondria and burn fat. In mice it worked: they ran farther and longer, muscle shifted toward endurance fibres, fat fell. Every one of those results is a mous</video:description>
<video:content_loc>https://zyratrack.com/media/slu-1-pill-847214f3.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>Its inventors say it does not work orally. Most swallow it. (2/9)</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/slu-2-oral-poster.jpg</video:thumbnail_loc>
<video:description>The 2026 paper introducing the successor compound describes SLU-PP-332 in its own abstract as a molecule that “improves aerobic performance in mice but lacks oral bioavailability”. The same laboratory then built a chemically distinct successor specifically because the original does not survive being</video:description>
<video:content_loc>https://zyratrack.com/media/slu-2-oral-713454b0.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>Half dose it in micrograms. Half in milligrams. Same compound. (3/9)</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/slu-3-units-poster.jpg</video:thumbnail_loc>
<video:description>Convert every reported SLU-PP-332 dose to a single unit and the community splits almost exactly in half: 100 reports describe less than a milligram, 112 describe a milligram or more. That is not a titration preference — it is a thousandfold disagreement about what kind of compound this is. The middl</video:description>
<video:content_loc>https://zyratrack.com/media/slu-3-units-f43bf693.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>52 said it worked. 7 said it did nothing. Why that is not evidence. (4/9)</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/slu-4-said-poster.jpg</video:thumbnail_loc>
<video:description>Of the 216 SLU-PP-332 reports we hold, 52 describe a positive result, 11 are mixed and 7 are explicitly negative. The remaining 146 state no outcome at all. Resist the obvious reading of 52-to-7: an uncontrolled, self-selected, publicly posted sample produces flattering ratios for essentially any in</video:description>
<video:content_loc>https://zyratrack.com/media/slu-4-said-0856c09f.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>The side effect people describe most: they run hot (5/9)</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/slu-5-hot-poster.jpg</video:thumbnail_loc>
<video:description>Fifteen of the 216 SLU-PP-332 reports we hold describe something adverse. That is a count from a self-selected public log, not an incidence rate — nobody here was followed up and under-reporting of harm is the expected bias. Within those fifteen the pattern repeats: raised heart rate in three report</video:description>
<video:content_loc>https://zyratrack.com/media/slu-5-hot-70c612f8.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>What the mice actually got — and by which route (6/9)</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/slu-6-mouse-poster.jpg</video:thumbnail_loc>
<video:description>Every efficacy claim about SLU-PP-332 traces back to mice, and in the exercise studies the compound was administered intraperitoneally — injected into the abdomen — not swallowed. What changed in those animals is real: they ran farther and longer, muscle shifted toward endurance fibres, and in obese</video:description>
<video:content_loc>https://zyratrack.com/media/slu-6-mouse-cef462f2.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>Anti-doping labs built a test for it before any human tried it (7/9)</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/slu-7-doping-poster.jpg</video:thumbnail_loc>
<video:description>Two of the seventeen papers we hold on SLU-PP-332 exist to detect it. They characterise the compound and its successor in vitro so a doping-control test knows what to look for. That produces an unusual scoreboard: the analytical science needed to catch this compound in an athlete is published and pe</video:description>
<video:content_loc>https://zyratrack.com/media/slu-7-doping-dab74524.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>The lab already made the oral version. It is not what is sold. (8/9)</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/slu-8-successor-poster.jpg</video:thumbnail_loc>
<video:description>SLU-PP-915 is the compound the same laboratory built to solve the oral problem: chemically distinct, and described in 2026 as orally bioavailable. In their tests it matched SLU-PP-332 on running distance and duration when injected, and maintained comparable efficacy given by mouth after adjusting fo</video:description>
<video:content_loc>https://zyratrack.com/media/slu-8-successor-17f59eb0.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>The version that works is the one nobody sells (BONUS)</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/slu-9-915-poster.jpg</video:thumbnail_loc>
<video:description>SLU-PP-915 is not offered for sale, and our log holds zero dose reports for it. Yet 14 separate discussions in our community corpus already name it — several citing the 2026 paper accurately to other readers, and asking why the version the inventors ruled out is the one being shipped. The correction</video:description>
<video:content_loc>https://zyratrack.com/media/slu-9-915-a19358b5.mp4</video:content_loc>
</video:video>
<lastmod>2026-08-21T12:32:42Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/mots-c-what-people-actually-take/</loc>
<video:video>
<video:title>MOTS-c: what the research actually shows (human vs mouse evidence)</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/mots-c-poster.jpg</video:thumbnail_loc>
<video:description>MOTS-c is a mitochondrial-derived peptide — 16 amino acids encoded inside your mitochondria&apos;s own DNA (MT-RNR1, the 12S rRNA gene), not the genome in the nucleus. In humans, exercise raises the MOTS-c you make, in muscle and in circulation. In mice, injected MOTS-c improved physical performance at e</video:description>
<video:content_loc>https://zyratrack.com/media/mots-c-d5806f45.mp4</video:content_loc>
</video:video>
<lastmod>2026-08-21T21:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/getting-started-with-zyra-labs/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/logging-your-first-dose/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/setting-up-reminders/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/using-the-reconstitution-calculator/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/seeing-your-medication-levels/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/managing-vials-and-inventory/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/best-peptide-tracker-apps/</loc>
<lastmod>2026-08-14T09:22:28Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-mk-677/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-ghrp-6/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-ghrp-2/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-pt-141/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-melanotan-ii/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-cagrilintide/</loc>
<lastmod>2026-07-20T12:00:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-aod-9604/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-hgh-fragment-176-191/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-tesofensine/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-slu-pp-332/</loc>
<video:video>
<video:title>SLU-PP-332: the exercise pill that only worked in mice (1/9)</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/slu-1-pill-poster.jpg</video:thumbnail_loc>
<video:description>SLU-PP-332 is sold as “exercise in a pill”. It is a synthetic pan-agonist of the ERR nuclear receptors — the switches muscle uses to build mitochondria and burn fat. In mice it worked: they ran farther and longer, muscle shifted toward endurance fibres, fat fell. Every one of those results is a mous</video:description>
<video:content_loc>https://zyratrack.com/media/slu-1-pill-847214f3.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>Its inventors say it does not work orally. Most swallow it. (2/9)</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/slu-2-oral-poster.jpg</video:thumbnail_loc>
<video:description>The 2026 paper introducing the successor compound describes SLU-PP-332 in its own abstract as a molecule that “improves aerobic performance in mice but lacks oral bioavailability”. The same laboratory then built a chemically distinct successor specifically because the original does not survive being</video:description>
<video:content_loc>https://zyratrack.com/media/slu-2-oral-713454b0.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>Half dose it in micrograms. Half in milligrams. Same compound. (3/9)</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/slu-3-units-poster.jpg</video:thumbnail_loc>
<video:description>Convert every reported SLU-PP-332 dose to a single unit and the community splits almost exactly in half: 100 reports describe less than a milligram, 112 describe a milligram or more. That is not a titration preference — it is a thousandfold disagreement about what kind of compound this is. The middl</video:description>
<video:content_loc>https://zyratrack.com/media/slu-3-units-f43bf693.mp4</video:content_loc>
</video:video>
<lastmod>2026-08-21T12:32:42Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-5-amino-1mq/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-bimagrumab/</loc>
<lastmod>2026-07-14T16:05:59Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-maritide/</loc>
<lastmod>2026-07-14T16:14:12Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-amycretin/</loc>
<lastmod>2026-07-14T16:19:39Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-semax/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-selank/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-epithalon/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-mots-c/</loc>
<video:video>
<video:title>MOTS-c: what the research actually shows (human vs mouse evidence)</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/mots-c-poster.jpg</video:thumbnail_loc>
<video:description>MOTS-c is a mitochondrial-derived peptide — 16 amino acids encoded inside your mitochondria&apos;s own DNA (MT-RNR1, the 12S rRNA gene), not the genome in the nucleus. In humans, exercise raises the MOTS-c you make, in muscle and in circulation. In mice, injected MOTS-c improved physical performance at e</video:description>
<video:content_loc>https://zyratrack.com/media/mots-c-d5806f45.mp4</video:content_loc>
</video:video>
<lastmod>2026-08-21T12:32:42Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-thymosin-alpha-1/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-kpv/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-survodutide/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-mazdutide/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-cagrisema/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-liraglutide/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-orforglipron/</loc>
<lastmod>2026-07-14T16:29:29Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-vk2735/</loc>
<lastmod>2026-07-14T16:35:14Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-pemvidutide/</loc>
<lastmod>2026-07-14T16:40:54Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-hexarelin/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-igf-1-lr3/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-kisspeptin-10/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-gonadorelin/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-ss-31/</loc>
<video:video>
<video:title>SS-31: The Trial That Finished — what a completed human trial found, and what 117 people did anyway</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/ss-film-poster.jpg</video:thumbnail_loc>
<video:description>The complete SS-31 (elamipretide) investigation in one film. There is an approved medicine in this story and there is an internet protocol — same molecule, different dose, different disease, different evidence. Ten chapters: the phase 3 that finished and missed (−3.2 metres, p 0.69); the post-hoc su</video:description>
<video:content_loc>https://zyratrack.com/media/ss-film-accd2d06.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>SS-31 finished a real phase 3 trial. It came back negative. (1/10)</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/ss-1-metres-poster.jpg</video:thumbnail_loc>
<video:description>Most research peptides never get a human trial. SS-31 (elamipretide) did: MMPOWER-3, 218 adults with primary mitochondrial myopathy, 24 weeks at 40 mg a day, against placebo. On the six-minute walk test the drug group finished 3.2 metres short of placebo (95% CI −18.7 to 12.3, p = 0.69). The fatigue</video:description>
<video:content_loc>https://zyratrack.com/media/ss-1-metres-2b2ddfb3.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>SS-31 is an approved medicine — for a disease almost nobody watching has (3/10)</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/ss-3-approval-poster.jpg</video:thumbnail_loc>
<video:description>Elamipretide, brand name Forzinity, is approved for Barth syndrome: a genetic mitochondrial disorder affecting about one child in every 300,000 to 400,000 born, almost always boys. Barth patients kept on the drug for years held their walking distance and heart measures through a 168-week extension,</video:description>
<video:content_loc>https://zyratrack.com/media/ss-3-approval-8f68991c.mp4</video:content_loc>
</video:video>
<video:video>
<video:title>SS-31 (elamipretide) is FDA approved — but read the label</video:title>
<video:thumbnail_loc>https://zyratrack.com/media/ss-31-poster.jpg</video:thumbnail_loc>
<video:description>SS-31, known by its drug name elamipretide, is the rare peptide in this space that actually cleared the FDA. It works at the inner mitochondrial membrane, stabilising cardiolipin — the phospholipid that holds the cristae in shape. Lose that structure and the mitochondrion stops making energy efficie</video:description>
<video:content_loc>https://zyratrack.com/media/ss-31-005aae62.mp4</video:content_loc>
</video:video>
<lastmod>2026-08-21T19:30:00Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-humanin/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-dsip/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-dihexa/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-nad-injection/</loc>
<lastmod>2026-07-14T17:23:47Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-klotho/</loc>
<lastmod>2026-07-14T17:29:37Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-ll-37/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-follistatin/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-melanotan-1/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-oxytocin/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-cerebrolysin/</loc>
<lastmod>2026-07-14T15:40:30Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://zyratrack.com/articles/what-is-lemon-bottle/</loc>
<lastmod>2026-07-14T17:35:55Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
</urlset>
